Wirano: a digital platform for organising clinical trials

A Dublin-based tech start-up has announced the launch of Wirano — a digital platform for the rapid and effective organisation of clinical trials.

Wirano is a global platform that aims to revolutionise the activities involved in clinical trials by accelerating start-up of trials, optimising patient recruitment and improving site and investigator selection processes. It is the brainchild of a team of international experts with over 20 years of experience in clinical research.

“The enormous cost of clinical trials in terms of time, money and effort is well known,” said Noel Quinn, Commercial Director. “The average clinical trial process lasts between 7.5 and 12 years, with costs ranging from $161 million to $2.6 billion per drug. Yet in spite of this investment, the success rate of clinical trials is just 14%.

“Wirano aims to improve this rate of success by optimising the patient recruitment process, improving site selection procedures and creating reliable channels for effective communications between all participants.”

One of the major challenges is searching for and selecting patients for trials, which is why 50% of all planned trials do not achieve recruitment targets on time. In fact, up to 11% of all trials do not recruit a single patient. In addition, the organisers of clinical trials often find it difficult to select a research centre with reliable data on previous experience and patient enrolment. The lack of a single database of centres from different countries and the absence of effective and reliable communication channels with research teams further aggravate the situation.

Wirano is designed to allow all participants of clinical trials, including pharmaceutical companies, medical researchers and patients, to effectively communicate throughout the process. Pharmaceutical companies (sponsors) will be able to quickly select research teams in different countries, doctors will be able to quickly post information about clinical trials for patients and start recruiting, and patients will have the possibility of finding a suitable clinical trial in a matter of minutes and apply for participation in it.

The Wirano project has completed pre-seed financing and is currently seeking investors to fully realise the power of its platform. The company plans to launch a module for patients and create a corresponding database by the end of the year 2020, with the first sponsors and research centres to be connected in 2021.

For more information, visit www.wirano.com.

Image credit: ©stock.adobe.com/au/Sergey Nivens

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.